论文部分内容阅读
恶性淋巴瘤为我国常见十大恶性肿瘤之一，因细胞成分不同，淋巴瘤分为何杰金氏病及非何杰金氏淋巴瘤两大类。后者的临床疗效及预后，远逊于前者，尤其是非何杰金氏淋巴瘤的Ⅲ、Ⅳ期患者，疗效更差。我们自1986～1995年采用中西医结合的方法，对34例Ⅲ、Ⅳ期非何杰金氏淋巴瘤患?
Malignant lymphoma is one of the ten most common malignant tumors in our country. Because of different cell components, lymphoma is divided into Hodgkin’s disease and non-Hodgkin’s lymphoma. The latter’s clinical efficacy and prognosis, far worse than the former, especially in non-Hodgkin’s lymphoma of stage Ⅲ, Ⅳ patients, even worse. We from 1986 to 1995 using the method of Integrative Medicine, 34 cases of stage Ⅲ, Ⅳ non-Hodgkin’s lymphoma?